References
- Global Report: UNAIDS report on Global Aids pandemic [Internet]. Switzerland: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2013 [cited 2016 May 25]. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Global_Report_2013_en_1.pdf
- Indian Pharmacopoeia (Volume 3). India: Indian Pharma-copoeia Commission, Ministry of Health and Family Welfare; 2007.
- Mesquita PMM, Rastogi R, Segarra TJ, et al. Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection. J Antimicrob Chemother. 2012;67:1730–1738.
- Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations [Internet]. US: Office of Generic drugs, Division of labeling and Program support; 2001 Oct 26 [updated 2013 July 25] [cited 2016 May 25]. Available from: http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=021356&TABLE1=OB_Rx.
- Gallant JE, Deresinski S. Tenofovir disoproxil fumarate. Clin Infect Dis. 2003;37:944–950.
- Aids Info: Offering information on HIV/AIDS treatment, prevention, and research [Internet]. US: Department of Health and Human Services; [updated 2017 April 13] [cited 2017 July 12]. Available from: https://aidsinfo.nih.gov/drugs/290/tenofovir-disoproxil-fumarate/0/patient
- Celum C, Baeten J. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evidence and evolving questions. Curr Opin Infect Dis. 2012;25:51–57.
- Clinical trials.gov. Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-001) [Internet]. US: National Institutes of Health; [updated 2015, Mar 23] [cited 2017 July 16]. Available from: https://clinicaltrials.gov/ct2/show/NCT02006264
- Acarturk F. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul. 2009;3:193–205.
- Pendergrass PB, Belovicz MW, Reeves CA. Surface area of the human vagina as measured from vinyl polysiloxane casts. Gynecol Obstet Invest. 2003;55:110–113.
- Indian Pharmacopoeia (Volume 1). India: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare; 2007.
- Guangyuan L, Lijun K, Baiyang S, et al. Degradation of covalently cross-linked carboxymethyl chitosan and its potential application for peripheral nerve regeneration. Eur Polym J. 2007;43:3807–3818.
- Yong CS, Choi JS, Quan QZ, et al. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int J Pharm. 2001;226:195–205.
- Smart JD, Dunkley S, Tsibouklis J, et al. An in vitro model for the evaluation of the adhesion of solid oral dosage forms to the oesophagus. Int J Pharm. 2013;447:199–203.
- Ghosh PK, Majithiya RJ, Manish L, et al. Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability. AAPS Pharm Sci Tech. 2006;7:171–177.
- Yadav M, Mishra T, Singhal P, et al. Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study. J Chromatogr Sci. 2009;47:140–148.
- Lozenski K, Ownbey R, Wigdahl B, et al. Decreased cervical epithelial sensitivity tononoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety. BMC Pharmacol Toxicol. 2012;13:1–11.
- ICH. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use [Internet]. Geneva: ICH Secretariat; 2003 [cited 2016 Feb 17]. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf
- Sahoo S, Chakraborti CK, Mishra SC. Qualitative analysis of controlled release ciprofloxacin/carbopol 934 mucoadhesive suspension. J Adv Pharm Tech Res. 2011;2:195–204.
- Gupta J, Tao JQ, Garg S, et al. Design and development of an in vitro assay for evaluation of solid vaginal dosage forms. Pharmacol Pharm. 2011;2:289–298.